TipRanks
Advanced BioMedical Technologies Inc. (ABMT)
OTHER OTC:ABMT
US Market
ABMT
Advanced BioMedical Technologies
RESEARCH TOOLSreports

Advanced BioMedical Technologies (ABMT) Income Statement

10 Followers

Advanced BioMedical Technologies Income Statement

Last quarter (Q3 2022), Advanced BioMedical Technologies's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q3, Advanced BioMedical Technologies's net income was $-189.79K. See Advanced BioMedical Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Oct 22Oct 21Oct 20Oct 19Oct 18
Total Revenue
$ 270.99K$ 171.19K$ 123.59K$ 11.66K$ 0.00
Gross Profit
$ 221.88K$ 93.30K$ 71.77K$ 4.06K$ 0.00
Operating Expenses
$ 401.76K$ 488.15K$ 518.39K$ 608.80K$ 634.02K
Depreciation and Amortization
$ 18.90K$ 41.28K$ 60.37K$ 21.15K$ 16.30K
EBITDA
$ -166.01K$ -367.44K$ -282.69K$ -601.26K$ -636.46K
Operating Income
$ -179.88K$ -394.86K$ -446.62K$ -604.74K$ -634.02K
Other Income/Expenses
$ -335.61K$ -334.58K$ -225.38K$ -344.08K$ -319.30K
Pretax Income
$ -515.49K$ -729.44K$ -672.00K$ -948.82K$ -953.32K
Net Income
$ -515.49K$ -729.44K$ -672.00K$ -948.82K$ -953.32K
Per Share Metrics
Basic EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.01
Diluted EPS
$ -0.01$ -0.01$ -0.01$ -0.01$ -0.01
Weighted Average Shares Outstanding
 70.61M 70.24M 69.94M 69.63M 69.38M
Weighted Average Shares Outstanding (Diluted)
 70.61M 70.24M 70.10M 69.63M 69.38M
Currency in USD

Advanced BioMedical Technologies Earnings and Revenue History